Myocardial Infarction Clinical Trial
— GOLD-PCIOfficial title:
A Study to Investigate the Protective Effects of Glucagon-like Peptide-1 (GLP-1) in Patients Undergoing Elective Angioplasty and Stenting (GOLD-PCI)
Verified date | June 2018 |
Source | Papworth Hospital NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Angina is caused by narrowings or blockages within coronary arteries. Coronary angioplasty
and stenting is performed for people with angina to improve the blood supply to the heart by
placing metal tubes within the artery using balloon inflation. The procedure risks small but
significant damage to the heart muscle downstream of the balloon.
Glucagon like peptide 1 (GLP 1) is a naturally occurring hormone secreted by cells in the gut
in response to food. It acts by stimulating the release of insulin. In the heart it acts to
increase glucose uptake into cardiac muscle. GLP−1 can protect the heart and improve heart
muscle performance in people with coronary artery disease in physiological studies. This
study which assesses whether GLP−1 protects the heart during coronary angioplasty and
stenting.
The hypothesis is that GLP-1 given during elective coronary angioplasty and stenting will
reduce cardiac troponin rise (a measure of heart muscle damage) compared to placebo.
Status | Active, not recruiting |
Enrollment | 193 |
Est. completion date | July 2021 |
Est. primary completion date | March 31, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria: - Undergoing elective PCI - Age over 18 - Able to give informed consent Exclusion criteria: - Severe co-morbidity (expected life expectancy < 6 months) - Nicorandil, glibenclamide, sitagliptin, vildagliptin, saxagliptin, linagliptin, liraglutide, exenatide and insulin use - Women of child bearing age - Breast-feeding women - Myocardial infarction within the previous 3 months - Baseline elevation of Troponin I before PCI - Chronic Renal Impairment (serum creatinine > 160 µmol/l) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Papworth Hospital | Cambridge | Cambridgeshire |
Lead Sponsor | Collaborator |
---|---|
Papworth Hospital NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Plasma Troponin I level | Incidence of Troponin I elevation of > 5 x 99th percentile upper reference limit on blood test at approximately 6 hours post procedure. | 6 Hours following angioplasty or stenting | |
Secondary | Major Adverse Cardiovascular or Cerebrovascular Event (MACCE) Rates | MACCE rate (death, stent thrombosis, myocardial infarction, acute coronary syndrome, hospitalisation with heart failure, stroke)- these will be patient reported and confirmed by interrogation of hospital records and interrogation of local and national databases. | From date of randomisation until the date of first event assessed up to 6 months | |
Secondary | Plasma Creatine Kinase - Myocardial Bound (CKMB) level | CKMB level on blood test at 6 hours following angioplasty or stenting | 6 hours | |
Secondary | Myocardial Flow Grade after Angioplasty or Stenting | Graded between 0 and 3 on Thrombolysis in Myocardial Infarction (TIMI) Scale | Measured during procedure | |
Secondary | MACCE Rates | MACCE rate (death, stent thrombosis, myocardial infarction, acute coronary syndrome, hospitalisation with heart failure, stroke)- these will be patient reported and confirmed by interrogation of hospital records and interrogation of local and national databases. | From date of randomisation until the date of first event assessed up to 12 months | |
Secondary | MACCE Rates | MACCE rate (death, stent thrombosis, myocardial infarction, acute coronary syndrome, hospitalisation with heart failure, stroke)- these will be patient reported and confirmed by interrogation of hospital records and interrogation of local and national databases. | From date of randomisation until the date of first event assessed up to 60 months | |
Secondary | Ischaemic symptoms during balloon occlusion | Presence or absence or of symptoms of myocardial ischaemia during the procedure | Assessed during procedure | |
Secondary | Myocardial Blush Grade following angioplasty or stenting | Graded between 0 and 3 on Thrombolysis in Myocardial Infarction (TIMI) Scale | Measured during procedure | |
Secondary | Electrocardiographic (ECG) Changes during procedure | Presence or absence of ECG changes reflective of myocardial ischaemia during the procedure | Assessed during procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
Completed |
NCT04507529 -
Peer-mentor Support for Older Vulnerable Myocardial Infarction Patients
|
N/A | |
Recruiting |
NCT06066970 -
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
|
||
Recruiting |
NCT03620266 -
Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
|
N/A | |
Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
Completed |
NCT04153006 -
Comparison of Fingerstick Versus Venous Sample for Troponin I.
|
||
Completed |
NCT03668587 -
Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
|
||
Recruiting |
NCT01218776 -
International Survey of Acute Coronary Syndromes in Transitional Countries
|
||
Completed |
NCT03076801 -
Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
|
N/A | |
Recruiting |
NCT05371470 -
Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation
|
N/A | |
Recruiting |
NCT04562272 -
Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP
|
N/A | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Not yet recruiting |
NCT06007950 -
Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health
|
N/A | |
Withdrawn |
NCT05327855 -
Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)
|
Phase 2 | |
Recruiting |
NCT02876952 -
High Intensity Aerobic Interval Training With Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients
|
N/A | |
Completed |
NCT02711631 -
Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02917213 -
Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
|
||
Completed |
NCT02382731 -
Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction
|
N/A | |
Completed |
NCT02305602 -
A Study of VentriGel in Post-MI Patients
|
Phase 1 |